Department of Microbiology, Chinese PLA General Hospital, Beijing, China.
Microb Drug Resist. 2011 Sep;17(3):363-7. doi: 10.1089/mdr.2011.0034. Epub 2011 May 12.
A total of 59 and 74 nonduplicate plasmid-mediated quinolone resistance (PMQR) genes-carrying Klebsiella pneumoniae and Escherichia coli isolates were collected. All strains were assayed for fluoroquinolone susceptibility and the prevalence of quinolone resistance-determining regions (QRDRs) mutation. The association between PMQR determinants and common β-lactamase genes was also analyzed. Genetic relatedness of the isolates was analyzed by pulsed-field gel electrophoresis (PFGE). The PMQR genes-carrying K. pneumoniae and E. coli isolates exhibited high fluoroquinolone resistance rates, indicating that PMQR determinants play an essential role in the development of fluoroquinolone resistance. Remarkably, most qnr-carrying strains had only a single or no QRDR mutation in GyrA or ParC, and most exhibited decreased ciprofloxacin (CIP) susceptibility or low-level CIP resistance. However, 71.4% and 98.4% of qnr-negative K. pneumoniae and E. coli contained double QRDR mutations, and most presented high-level CIP resistance. Additionally, K. pneumoniae presented a lower CIP resistance rate than E. coli (59.3% vs. 91.9%) and low carriage of double QRDR mutations (38.9% vs. 89.9%). Also, most (88.1%) K. pneumoniae examined in this study carried qnr and only 14.9% of E. coli were qnr positive. Thus, the high fluoroquinolone susceptibility of K. pneumoniae isolates is primarily due to fewer QRDR substitutions as a result of high prevalence of qnr alleles in the host. Our findings support the hypothesis that chromosomal resistance mutations could be affected by the presence of Qnr, in other words, Qnr may protect the QRDR domains in the gyrase and topoisomerase IV from mutations under the inhibition of fluoroquinolones. Another remarkable finding was that the PMQR genes-carrying K. pneumoniae exhibited much higher proportions of extended-spectrum β-lactamases (ESBLs)-positive phenotype than E. coli (73.5% vs. 59.5%). This is due to not only the high prevalence of SHV-type ESBL-conferring enzymes in K. pneumoniae but also the interference of DHA-producing K. pneumoniae as a result of the strong association between qnrB and bla(DHA).
共收集了 59 株和 74 株非重复的质粒介导的喹诺酮类耐药(PMQR)基因的肺炎克雷伯菌和大肠埃希菌分离株。所有菌株均进行了氟喹诺酮类药物敏感性检测和喹诺酮类耐药决定区(QRDRs)突变的检测。还分析了 PMQR 决定因素与常见β-内酰胺酶基因之间的关系。通过脉冲场凝胶电泳(PFGE)分析了分离株的遗传相关性。携带 PMQR 基因的肺炎克雷伯菌和大肠埃希菌分离株表现出高氟喹诺酮类药物耐药率,表明 PMQR 决定因素在氟喹诺酮类药物耐药的发展中起重要作用。值得注意的是,大多数 qnr 携带株在 GyrA 或 ParC 中只有单个或没有 QRDR 突变,大多数对环丙沙星(CIP)的敏感性降低或表现为低水平 CIP 耐药。然而,71.4%的 qnr 阴性肺炎克雷伯菌和 98.4%的大肠埃希菌含有双重 QRDR 突变,且大多数表现为高水平 CIP 耐药。此外,肺炎克雷伯菌的 CIP 耐药率低于大肠埃希菌(59.3%对 91.9%),且双重 QRDR 突变的携带率较低(38.9%对 89.9%)。此外,本研究中大多数(88.1%)肺炎克雷伯菌携带 qnr,而只有 14.9%的大肠埃希菌携带 qnr。因此,肺炎克雷伯菌分离株具有较高的氟喹诺酮类药物敏感性,主要是由于 QRDR 取代较少,这是由于宿主中 qnr 等位基因的高流行率所致。我们的研究结果支持这样一种假设,即染色体耐药突变可能受到 Qnr 的影响,换句话说,Qnr 可能在氟喹诺酮类药物的抑制下保护拓扑异构酶和拓扑异构酶 IV 的 QRDR 结构域免受突变。另一个显著的发现是,携带 PMQR 基因的肺炎克雷伯菌表现出比大肠埃希菌更高比例的超广谱β-内酰胺酶(ESBLs)阳性表型(73.5%对 59.5%)。这不仅是由于肺炎克雷伯菌中 SHV 型 ESBL 酶的高流行率,还由于 bla(DHA)和 qnrB 之间的强关联导致 DHA 产生的肺炎克雷伯菌的干扰。